Sesen Bio, Inc. (SESN) Stock Analysis
DELISTED 2023
What happened to Sesen Bio, Inc. (SESN) stock?
Sesen Bio, Inc. (SESN) no longer trades on public markets. It was delisted in March 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2023
- Last recorded price (historical):
- $0.6288 (last quote on record before the March 2023 delisting; historical, not a current quote)
P/E 1.01 means the share price is 1.01 times one year of earnings per share. Market cap $128M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Sesen Bio, Inc. (SESN). Sesen Bio, Inc. is a clinical-stage biotechnology firm focused on developing targeted fusion protein therapeutics for cancer treatment.
Last analyzed: Jun 15, 2026Sesen Bio, Inc. (SESN) Healthcare & Pipeline Overview
More about this archive record
Can I still buy SESN shares?
No. SESN stopped trading on public markets in March 2023, so the shares are not available through a broker. Anything you see quoted for SESN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SESN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Sesen Bio, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.